Spain· ES:10268-12-02-2007
ARTEDIL 20 mg COMPRIMIDOS
A medicinal product containing manidipino, registered in Spain by Chiesi Hellas S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- manidipino
- Manufacturer
- Chiesi Hellas S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo72831228EUR 14.17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Manidipino in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyERREMANPHARMACARE S.R.L.
- FranceIPERTEN 20 mg, compriméCHIESI
- United KingdomIperten 20mg tabletsImported (France)
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Iperten, Manidipine Arrow
- Greece · Manyper, Presidin
- Italy · Erreman, Iperten
- Portugal · Manidipina Generis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/826e1374-b5e7-4c15-b308-d1b462c7fe91 GET /v1/drugs/826e1374-b5e7-4c15-b308-d1b462c7fe91?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1587029890000}",
"nregistro": "10268-12-02-2007",
"substance": "manidipino"
}See everything about manidipino.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.